secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000950170-24-122575
Event type: earnings
Sentiment:  positive
Materiality: 0.72
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q3 revenue $312.7M (+19% YoY); raises FY2024 guidance on Adj. EBITDA to $105-115M
--------------------------------------------------------------------------------

- Revenue $312.7M (+19% YoY); net loss improved to $6.0M from $61.6M; Adjusted EBITDA $30.7M (+110%).
- Clinician base 7,269 (+13% YoY); visit volumes 2.0M (+15%); Center Margin $100.4M (32.1% of revenue, +32%).
- FY2024 guidance raised: revenue $1.228B-$1.248B; Adj. EBITDA $105M-$115M; positive Free Cash Flow reiterated.
- Q4 2024 guidance: revenue $302.5M-$322.5M; Adj. EBITDA $18M-$28M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024122575/0000950170-24-122575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024122575/lfst-20241107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer